Barrett Business Services Inc. (NASDAQ:BBSI) had its target price lifted by Roth Capital from $45.00 to $54.00 in a research note released on Monday morning. They currently have a buy rating on the stock. On Monday shares of Barrett Business Services Inc. (NASDAQ:BBSI) closed at $29.32. Company’s sales growth for last 5 years was 13.70% and EPS growth for next 5 years is recorded as 10.00%.
On 6 January Echo Therapeutics, Inc. (NASDAQ:ECTE) announced that the Company rehired key members of its Research & Development team to support the implementation of a new corporate strategy. The Research & Development team, led by Tom Bishop, Vice President of Operations and Product Development, will refine and adapt Echo’s current core transdermal technology for consumer and medical applications in analyte measurement. Echo Therapeutics, Inc. (NASDAQ:ECTE) in last trading activity moved up 10.19% to close at $2.27. Company weekly performance is 53.38% while its quarterly performance stands at 198.68%. Echo Therapeutics, Inc. (NASDAQ:ECTE) is -43.53% away from its 52 week high.
On 9 January Banco Santander, S.A. (NYSE:SAN) said it plans to sell shares for as much as 7.5 billion euros ($8.8 billion) and will cut its dividend, reducing the payout it had offered investors since 2007. On Monday shares of Banco Santander, S.A. (NYSE:SAN) closed at $6.91. Company’s sales growth for last 5 years was -1.30% and EPS growth for next 5 years is recorded as 9.90%.
Unisys Corporation (NYSE:UIS) said that it will release its fourth-quarter and full-year 2014 financial results on Thursday, January 29, 2015 after the close of trading on the New York Stock Exchange. On last trading day Unisys Corporation (NYSE:UIS) fell -1.09% to close at $27.11. Its volatility for the week is 2.65% while volatility for the month is 3.09%. UIS’s sales growth for past 5 years was -6.90% and its EPS growth for past 5 years was 20.10%. Unisys Corporation (NYSE:UIS) monthly performance is 6.99%.
On 6 January Johnson & Johnson (NYSE:JNJ) said that it has started human trials on a possible vaccine against Ebola. On last trading day Johnson & Johnson (NYSE:JNJ) decreased -0.34% to close at $104.58. Its volatility for the week is 1.55% while volatility for the month is 1.57%. JNJ’s sales growth for past 5 years was 2.30% and its EPS growth for past 5 years was 1.00%. Johnson & Johnson (NYSE:JNJ) monthly performance is -1.56%.